Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by electroCore, Inc.

electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore to Participate at 35th Annual Roth Conference
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore Announces Reverse Stock Split
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore Regains Compliance with Nasdaq Listing Requirements
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore Completes Sale of New Jersey Tax Benefits
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore Announces Expected Record 4Q 2022 Revenue of $2.5M; Provides Business Update
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore, Inc. Launches New Wellness Product Offering for Stress, Anxiety and Sleep, Truvaga™
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore Announces Issuance of Two New U.S. Patents
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
gammaCore Sapphire™ Non-Invasive Vagus Nerve Stimulator (nVNS) Receives Unique National Product Code Number by the Belgian Pharmaceutical Association
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore to Participate at Canaccord Genuity MedTech and Diagnostics and Digital Health & Services Forum
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore, Inc. Announces Distribution Agreement with Joerns Healthcare, LLC
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore to Announce Third Quarter 2022 Financial Results on November 3
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Neurobehavioral Outcomes in a Model of Traumatic Brain Injury
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
electroCore Provides Select Third Quarter 2022 Financial Guidance
From electroCore, Inc.
Via GlobeNewswire
Tickers ECOR
Migraine and Headache Awareness Month: gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Treats & Prevents Migraine and Cluster Headaches
From electroCore, Inc.
Via Business Wire
The Ins & Outs of nVNS: Non-Invasive Vagus Nerve Stimulation Device Prevents and Relieves Pain From Migraines, Cluster Headaches & Other Conditions
From electroCore, Inc.
Via Business Wire
electroCore, Inc. Celebrates Veterans and Active Members of the Military During National Military Appreciation Month
From electroCore, Inc.
Via Business Wire
electroCore Supports Results of Lancet Paper Highlighting the Benefits of Vagus Nerve Stimulation for Stroke Patients
From electroCore, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.